Identification Generic Name (2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-L-PROLINAMIDE DrugBank Accession Number DB07482 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 Download  MOL SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-L-PROLINAMIDE (DB07482) ×  Close Weight Average: 212.054  Monoisotopic: 212.133222886  Chemical Formula C 9 H 17 BN 2 O 3 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Dipeptidyl peptidase 4 Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as alpha amino acid amides. These are amide derivatives of alpha amino acids. Kingdom Organic compounds Super Class Organic acids and derivatives Class Carboxylic acids and derivatives Sub Class Amino acids, peptides, and analogues Direct Parent Alpha amino acid amides Alternative Parents Pyrrolidinecarboxamides  /  N-acylpyrrolidines  /  Tertiary carboxylic acid amides  /  Boronic acids  /  Organic metalloid salts  /  Dialkylamines  /  Azacyclic compounds  /  Organopnictogen compounds  /  Organic oxides  /  Monoalkylboranes  /  Hydrocarbon derivatives  /  Carbonyl compounds 
 
 
  show 2 more Substituents Aliphatic heteromonocyclic compound  /  Alkylborane  /  Alpha-amino acid amide  /  Amine  /  Azacycle  /  Boronic acid  /  Boronic acid derivative  /  Carbonyl group  /  Carboxamide group  /  Hydrocarbon derivative  /  Monoalkylborane  /  N-acylpyrrolidine  /  Organic metalloid salt  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organic salt  /  Organoboron compound  /  Organoheterocyclic compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Pyrrolidine  /  Pyrrolidine carboxylic acid or derivatives  /  Pyrrolidine-2-carboxamide  /  Secondary aliphatic amine  /  Secondary amine  /  Tertiary carboxylic acid amide 
 
 
  show 18 more Molecular Framework Aliphatic heteromonocyclic compounds External Descriptors L-proline derivative, N-acylpyrrolidine, boronic acids ( CHEBI:41285 )  Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key XSBZZZGVAIXJLD-YUMQZZPRSA-N InChI InChI=1S/C9H17BN2O3/c13-9(7-3-1-5-11-7)12-6-2-4-8(12)10(14)15/h7-8,11,14-15H,1-6H2/t7-,8-/m0/s1 IUPAC Name [(2R)-1-[(2S)-pyrrolidine-2-carbonyl]pyrrolidin-2-yl]boronic acid SMILES [H][C@]1(CCCN1C(=O)[C@]1([H])CCCN1)B(O)O References General References Not Available External Links PubChem Compound 10198228 PubChem Substance 99443953 ChemSpider 8373728 BindingDB 50050521 ChEBI 41285 ChEMBL CHEMBL63895 ZINC ZINC000169748497 PDBe Ligand BPR PDB Entries 2ajd Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 30.2 mg/mL ALOGPS logP -0.52 ALOGPS logP -1.3 Chemaxon logS -0.85 ALOGPS pKa (Strongest Acidic) 8.61 Chemaxon pKa (Strongest Basic) 9.85 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 3 Chemaxon Polar Surface Area 72.8 Å 2 Chemaxon Rotatable Bond Count 2 Chemaxon Refractivity 50.91 m 3 ·mol -1 Chemaxon Polarizability 22.52 Å 3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.703 Blood Brain Barrier + 0.7807 Caco-2 permeable - 0.6567 P-glycoprotein substrate Substrate 0.5372 P-glycoprotein inhibitor I Non-inhibitor 0.8954 P-glycoprotein inhibitor II Non-inhibitor 0.9891 Renal organic cation transporter Non-inhibitor 0.8368 CYP450 2C9 substrate Non-substrate 0.797 CYP450 2D6 substrate Non-substrate 0.731 CYP450 3A4 substrate Non-substrate 0.683 CYP450 1A2 substrate Non-inhibitor 0.871 CYP450 2C9 inhibitor Non-inhibitor 0.8726 CYP450 2D6 inhibitor Non-inhibitor 0.8895 CYP450 2C19 inhibitor Non-inhibitor 0.8048 CYP450 3A4 inhibitor Non-inhibitor 0.9172 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9479 Ames test Non AMES toxic 0.6165 Carcinogenicity Non-carcinogens 0.884 Biodegradation Not ready biodegradable 0.6683 Rat acute toxicity 2.1213 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9484 hERG inhibition (predictor II) Non-inhibitor 0.8428    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more Binding Properties × Property Measurement pH Temperature (°C) References IC 50 (nM) 20 N/A N/A A30867 Ki (nM) 3 N/A N/A A18427 
 
 
  Details 
 
 
   Binding Properties 1.  Dipeptidyl peptidase 4 Kind Protein Organism Humans Pharmacological action Unknown General Function Virus receptor activity Specific Function Cell surface glycoprotein receptor involved in the costimulatory signal essential for T-cell receptor (TCR)-mediated T-cell activation. Acts as a positive regulator of T-cell coactivation, by bindi... Gene Name DPP4 Uniprot ID P27487 Uniprot Name Dipeptidyl peptidase 4 Molecular Weight 88277.935 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:22 / Updated at June 12, 2020 16:52 